Prognostic factors affecting early colectomy in patients with moderate to severe ulcerative colitis treated with calcineurin inhibitors

被引:8
|
作者
Ban, Hiromitsu [1 ]
Bamba, Shigeki [2 ]
Nishida, Atsushi [2 ]
Inatomi, Osamu [2 ]
Shioya, Makoto [2 ]
Takahashi, Ken-Ichiro [2 ]
Imaeda, Hirotsugu [2 ]
Murata, Masaki [2 ]
Sasaki, Masaya [3 ]
Tsujikawa, Tomoyuki [4 ]
Andoh, Akira [2 ]
机构
[1] Shiga Univ Med Sci, Div Endoscopy, Otsu, Shiga 5202192, Japan
[2] Shiga Univ Med Sci, Div Gastroenterol, Otsu, Shiga 5202192, Japan
[3] Shiga Univ Med Sci, Div Clin Nutr, Otsu, Shiga 5202192, Japan
[4] Shiga Univ Med Sci, Dept Comprehens Internal Med, Otsu, Shiga 5202192, Japan
关键词
ulcerative colitis; colectomy; calcineurin inhibitors; cyclosporine A; tacrolimus; INFLAMMATORY-BOWEL-DISEASE; NUTRITIONAL INDEX; RESCUE THERAPY; TNF-ALPHA; CYCLOSPORINE; INFLIXIMAB; CYTOMEGALOVIRUS; GUIDELINES; ADULTS; MANAGEMENT;
D O I
10.3892/etm.2016.3341
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Calcineurin inhibitors (CNIs) such as cyclosporine A (CSA) and tacrolimus (FK506) are often used as a second-line drug for steroid-refractory or steroid-dependent patients with ulcerative colitis (UC). The aim of the present study was to determine the prognostic factors for early colectomy. A total of 85 hospitalized patients with UC (CSA, 50 patients; FK506, 35 patients) were enrolled. Colectomy carried out within 60 days of starting CNI therapy was defined as. early colectomy'. To assess the prognostic factors affecting early colectomy, clinical practical variables, including the Onodera-prognostic nutritional index (O-PNI): 10xAlb+0.005x (total lymphocyte count), were analyzed. The results demonstrated that the significant factors predicting early colectomy were i) disease severity, ii) immunomodulator-naive history, iii) lower serum hematocrit, iv) lower serum albumin and v) lower O-PNI. In addition, the significant factors predicting overall colectomy were as follows: i) C7-HRP positivity and ii) >10,000 mg of prednisolone used prior to the initiation of CNI treatment. The combination of hematocrit and O-PNI enhanced the prediction of early colectomy. Clinical variables such as hematocrit and O-PNI were the significant factors predicting colectomy. These results may be used as a guide to predict the outcome of patients with UC in clinical settings.
引用
收藏
页码:829 / 834
页数:6
相关论文
共 50 条
  • [21] Prevalence and risk factors for early medical and surgical complications following an admission for acute severe ulcerative colitis
    Li, Angel
    Coote, Matthew
    Thin, Lena
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [22] Colectomy with ileostomy for severe ulcerative colitis-postoperative complications and risk factors
    C. Schineis
    K. S. Lehmann
    J. C. Lauscher
    K. Beyer
    L. Hartmann
    G. A. Margonis
    J. Michel
    C. E. Degro
    F. N. Loch
    F. Speichinger
    M. E. Kreis
    C. Kamphues
    International Journal of Colorectal Disease, 2020, 35 : 387 - 394
  • [23] Early readmission in patients hospitalized for ulcerative colitis: incidence and risk factors
    Tinsley, Andrew
    Naymagon, Steven
    Mathers, Bradley
    Kingsley, Michael
    Sands, Bruce E.
    Ullman, Thomas A.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1103 - 1109
  • [24] The importance of sarcopenia as a prognostic predictor of the clinical course in acute severe ulcerative colitis patients
    Ge, Xiaolong
    Jiang, Liping
    Yu, Weihua
    Wu, Yan
    Liu, Wei
    Qi, Weilin
    Cao, Qian
    Bai, Rongpan
    Zhou, Wei
    DIGESTIVE AND LIVER DISEASE, 2021, 53 (08) : 965 - 971
  • [25] Severe Diffuse Duodenitis Successfully Treated with Intravenous Tacrolimus after Colectomy for Ulcerative Colitis
    Saito, Keiko
    Katsuno, Tatsuro
    Nakagawa, Tomoo
    Minemura, Shoko
    Oyamada, Arata
    Kanogawa, Naoya
    Saito, Masaya
    Yoshihama, Sayuri
    Maruoka, Daisuke
    Matsumura, Tomoaki
    Arai, Makoto
    Tohma, Takayuki
    Miyauchi, Hideaki
    Matsubara, Hisahiro
    Yokosuka, Osamu
    INTERNAL MEDICINE, 2014, 53 (21) : 2477 - 2481
  • [26] Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
    Feagan, Brian G.
    Schreiber, Stefan
    Wolf, Douglas C.
    Axler, Jeffrey L.
    Kaviya, Arpeat
    James, Alexandra
    Curtis, Rebecca I.
    Geransar, Parnia
    Stallmach, Andreas
    Ehehalt, Robert
    Bokemeyer, Bernd
    Khalid, Javaria Mona
    O'Byrne, Sharon
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (06) : 1028 - 1035
  • [27] Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative Colitis
    Vong, Camille
    Martin, Steven W.
    Deng, Chenhui
    Xie, Rujia
    Ito, Kaori
    Su, Chinyu
    Sandborn, William J.
    Mukherjee, Arnab
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (03): : 229 - 240
  • [28] Risk factors for arthropathy in patients with ulcerative colitis after total colectomy
    Noda, Kentaro
    Okita, Yoshiki
    Mizutani, Yuki
    Sugitani, Naohiro
    Suzuki, Yasuo
    Kusunoki, Masato
    Nakajima, Ayako
    MODERN RHEUMATOLOGY, 2021, 31 (02) : 468 - 473
  • [29] Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis
    Zheng, Jieqi
    Fan, Zinan
    Li, Chao
    Wang, Daiyue
    Zhang, Shenghong
    Chen, Rirong
    BMJ OPEN GASTROENTEROLOGY, 2024, 11 (01):
  • [30] Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis
    Ollrch, Jacob E.
    Dwadasi, Sujaata
    Rai, Victoria
    Peleg, Noam
    Normatov, Inessa
    Israel, Amanda
    Sossenheimer, Philip H.
    Christensen, Britt
    Pekow, Joel
    Dalal, Sushila R.
    Sakuraba, Atsushi
    Cohen, Russell D.
    Rubin, David T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (06) : 637 - 643